Department of Interventional Radiology, School of Medicine, Patras University Hospital, 26504, Rion, Patras, Greece.
Cardiovasc Intervent Radiol. 2013 Aug;36(4):943-9. doi: 10.1007/s00270-012-0516-8. Epub 2012 Nov 14.
Application of metal stents is complicated by neointimal hyperplasia leading to vessel restenosis and reocclusion. Treatment options in cases presenting with complete occlusion of the stented segment and recurrent critical limb ischemia (CLI) are limited. We present the option of the subintimal/substent technique in dealing with occluded stents.
The study included patients presenting with recurrent CLI due to impaired blood flow as a result of complete occlusion of previously inserted metal stents and unsuccessful intraluminal crossing of the lesion via either the antegrade or retrograde approach. In these cases, crossing the occlusion through the subintimal/substent plane was attempted. Primary end points included technical success, safety of the procedure, clinical improvement, and limb salvage, while secondary end points were patient survival, primary patency, and vessel restenosis rates at 1-year follow-up. Study end points were calculated by Kaplan-Meier survival analysis.
Between July 2006 and October 2011, a total of 14 patients (mean age 69.14 ± 12.59 years, 12 men) were treated with the substent technique and included in the analysis. Technical success rate was 85.71% (12 of 14), with a total lesion length of 193.57 ± 90.78 mm. The mean occluded stented segment length was 90.21 ± 44.34 mm. In 10 (83.33%) of 12 cases, a new stent had to be placed by the side of the old occluded one, while the remaining two cases (16.67%) were treated only with balloon angioplasty. No serious adverse events were noted during the immediate postprocedural period. All successfully treated patients improved clinically. Estimated limb salvage was 90.9%, and patient survival rate was 90.0% at 1 year's follow-up. Primary patency was 45.50% and vessel restenosis 77.30%.
Subintimal recanalization of occluded metal stents through the substent plane is a valuable alternative treatment option, especially in patients with recurrent CLI with few alternatives.
金属支架的应用因新生内膜过度增生导致血管再狭窄和再闭塞而变得复杂。在支架段完全闭塞和复发性严重肢体缺血(CLI)的情况下,治疗选择有限。我们提出了一种在处理闭塞支架时使用内膜下/支架下技术的选择。
本研究纳入了因先前植入的金属支架完全闭塞和经顺行或逆行腔内途径未能成功穿过病变而导致血流受损、出现复发性 CLI 的患者。在这些情况下,尝试通过内膜下/支架下平面穿过闭塞处。主要终点包括技术成功、手术安全性、临床改善和肢体挽救,次要终点包括患者生存、原发性通畅率和 1 年随访时的血管再狭窄率。研究终点通过 Kaplan-Meier 生存分析计算。
2006 年 7 月至 2011 年 10 月,共有 14 例(平均年龄 69.14 ± 12.59 岁,12 例男性)接受了支架下技术治疗,并纳入分析。技术成功率为 85.71%(12/14),总病变长度为 193.57 ± 90.78 mm。平均闭塞支架段长度为 90.21 ± 44.34 mm。在 12 例中的 10 例(83.33%)中,需要在旧闭塞支架旁边放置新支架,而其余 2 例(16.67%)仅接受球囊血管成形术治疗。在即刻术后期间未发生严重不良事件。所有成功治疗的患者均获得临床改善。估计肢体挽救率为 90.9%,患者 1 年生存率为 90.0%。原发性通畅率为 45.50%,血管再狭窄率为 77.30%。
通过支架下平面对闭塞的金属支架进行内膜下再通是一种有价值的替代治疗选择,特别是在复发性 CLI 患者且治疗选择有限的情况下。